167 related articles for article (PubMed ID: 22503846)
1. Connective tissue growth factor (CTGF/CCN2): a protagonist in cardiac allograft vasculopathy development?
Pantou MP; Manginas A; Alivizatos PA; Degiannis D
J Heart Lung Transplant; 2012 Aug; 31(8):881-7. PubMed ID: 22503846
[TBL] [Abstract][Full Text] [Related]
2. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
[TBL] [Abstract][Full Text] [Related]
3. From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation.
Valantine H; Zuckermann A
J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S185-90; discussion S210-1. PubMed ID: 15774320
[TBL] [Abstract][Full Text] [Related]
4. Late acute cardiac allograft rejection: new therapeutic options?
Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
[TBL] [Abstract][Full Text] [Related]
5. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation.
Raichlin E; Edwards BS; Kremers WK; Clavell AL; Rodeheffer RJ; Frantz RP; Pereira NL; Daly RC; McGregor CG; Lerman A; Kushwaha SS
J Heart Lung Transplant; 2009 Apr; 28(4):320-7. PubMed ID: 19332257
[TBL] [Abstract][Full Text] [Related]
6. Urinary connective tissue growth factor increases far earlier than histopathological damage and functional deterioration in early chronic renal allograft injury.
Shi Y; Tu Z; Bao J; Sun H; Wang W; Luo G; Li S; Li Y; Bu H
Scand J Urol Nephrol; 2009; 43(5):390-9. PubMed ID: 19921985
[TBL] [Abstract][Full Text] [Related]
7. Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathy.
Heikal NM; Bader FM; Martins TB; Pavlov IY; Wilson AR; Barakat M; Stehlik J; Kfoury AG; Gilbert EM; Delgado JC; Hill HR
Transplant Proc; 2013; 45(1):376-82. PubMed ID: 23267802
[TBL] [Abstract][Full Text] [Related]
8. Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis.
Viganò M; Tuzcu M; Benza R; Boissonnat P; Haverich A; Hill J; Laufer G; Love R; Parameshwar J; Pulpón LA; Renlund D; Abeywickrama K; Cretin N; Starling RC; Eisen HJ;
J Heart Lung Transplant; 2007 Jun; 26(6):584-92. PubMed ID: 17543781
[TBL] [Abstract][Full Text] [Related]
9. Recipient genotype is a predictor of allograft cytokine expression and outcomes after pediatric cardiac transplantation.
Auerbach SR; Manlhiot C; Reddy S; Kinnear C; Richmond ME; Gruber D; McCrindle BW; Deng L; Chen JM; Addonizio LJ; Chung WK; Mital S
J Am Coll Cardiol; 2009 May; 53(20):1909-17. PubMed ID: 19442892
[TBL] [Abstract][Full Text] [Related]
10. Increased vascular endothelial growth factor mRNA in endomyocardial biopsies from allografts demonstrating severe acute rejection: a longitudinal study.
Bayliss J; Maguire JA; Bailey M; Leet A; Kaye D; Richardson M; Bergin PJ; Dowling J; Thomson NM; Stein AN
Transpl Immunol; 2008 Jan; 18(3):264-74. PubMed ID: 18047936
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy.
Tambur AR; Pamboukian S; Costanzo MR; Heroux A
J Heart Lung Transplant; 2006 Jun; 25(6):690-8. PubMed ID: 16730575
[TBL] [Abstract][Full Text] [Related]
12. Correlation between circulating endothelial progenitor cell function and allograft rejection in heart transplant patients.
Sathya CJ; Sheshgiri R; Prodger J; Tumiati L; Delgado D; Ross HJ; Rao V
Transpl Int; 2010 Jun; 23(6):641-8. PubMed ID: 20102553
[TBL] [Abstract][Full Text] [Related]
13. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
[TBL] [Abstract][Full Text] [Related]
14. Increased connective tissue growth factor expression in a rat model of chronic heart allograft rejection.
Yuan YC; Xia ZK; Mu JJ; Zhang QC; Yin BL
J Formos Med Assoc; 2009 Mar; 108(3):240-6. PubMed ID: 19293040
[TBL] [Abstract][Full Text] [Related]
15. Can HLA-G polymorphisms predict the development of cardiac allograft vasculopathy?
Mociornita AG; Lim-Shon J; Joseph JM; Ross HJ; Rao V; Delgado DH
Hum Immunol; 2013 Apr; 74(4):464-7. PubMed ID: 23261409
[TBL] [Abstract][Full Text] [Related]
16. CD34+CD140b+ cells and circulating CXCL12 correlate with the angiographically assessed severity of cardiac allograft vasculopathy.
Schober A; Hristov M; Kofler S; Forbrig R; Löhr B; Heussen N; Zhe Z; Akhtar S; Schumann U; Krötz F; Leibig M; König A; Kaczmarek I; Reichart B; Klauss V; Weber C; Sohn HY
Eur Heart J; 2011 Feb; 32(4):476-84. PubMed ID: 21036775
[TBL] [Abstract][Full Text] [Related]
17. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.
Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A
Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779
[TBL] [Abstract][Full Text] [Related]
18. Expression of connective tissue growth factor in acute heart allograft rejection in rats.
Yuan YC; Xia ZK; Zhang QC; Yin BL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):425-31. PubMed ID: 18544847
[TBL] [Abstract][Full Text] [Related]
19. Low serum IGF-1 is a risk factor for cardiac allograft vasculopathy in cardiac transplant recipients.
Aharinejad S; Salama M; Rödler S; Ehrlich M; Zuckermann A; Laufer G
Transplantation; 2012 Feb; 93(3):309-13. PubMed ID: 22217530
[TBL] [Abstract][Full Text] [Related]
20. Rapidly progressive cardiac allograft vasculopathy in early onset regressed with everolimus treatment in an adult cardiac recipient.
Ishida J; Kinugawa K; Shiga T; Imamura T; Hatano M; Maki H; Inaba T; Yao A; Hirata Y; Nishimura T; Kyo S; Ono M; Nagai R
Int Heart J; 2012; 53(6):388-90. PubMed ID: 23258141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
